These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 16625817

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Obesity: a review of currently used antiobesity drugs and new compounds in clinical development].
    Zieba R.
    Postepy Hig Med Dosw (Online); 2007 Oct 19; 61():612-26. PubMed ID: 17971763
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacotherapy for obesity.
    Neff LM, Aronne LJ.
    Curr Atheroscler Rep; 2007 Dec 19; 9(6):454-62. PubMed ID: 18377785
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology of appetite suppression: implication for the treatment of obesity.
    Halford JC.
    Curr Drug Targets; 2001 Dec 19; 2(4):353-70. PubMed ID: 11732637
    [Abstract] [Full Text] [Related]

  • 11. Translational studies on PYY as a novel target in obesity.
    Zac-Varghese S, De Silva A, Bloom SR.
    Curr Opin Pharmacol; 2011 Dec 19; 11(6):582-5. PubMed ID: 22019565
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-obesity drugs.
    Proietto J.
    Med J Aust; 1998 Apr 20; 168(8):409-12. PubMed ID: 9594954
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug treatment of obesity.
    Bray GA.
    Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Apr 20; 13(1):131-48. PubMed ID: 10932681
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
    Pavón FJ, Serrano A, Pérez-Valero V, Jagerovic N, Hernández-Folgado L, Bermúdez-Silva FJ, Macías M, Goya P, de Fonseca FR.
    J Neuroendocrinol; 2008 May 20; 20 Suppl 1():116-23. PubMed ID: 18426510
    [Abstract] [Full Text] [Related]

  • 20. Effects of combined oleoyl-estrone and rimonabant on overweight rats.
    Ferrer-Lorente R, Cabot C, Fernández-López JA, Alemany M.
    J Pharmacol Sci; 2007 Jun 20; 104(2):176-82. PubMed ID: 17558182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.